Home › Funds › Perbak Capital Partners LLP › CVS
Perbak Capital Partners LLP position in CVS
CVS HEALTH CORP · Consumer Staples
Perbak Capital Partners LLP reported holding 20,078 shares of CVS (CVS HEALTH CORP) in its Q1 2026 13F filing — a position valued at US$1.4M, representing 0.35% of its reported portfolio and ranking #32 among its reported holdings. Perbak Capital Partners LLP first reported this position in Q1 2026.
Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR
How Perbak Capital Partners LLP's CVS position evolved
Perbak Capital Partners LLP first disclosed a stake in CVS in Q1 2026 at 20,078 shares (US$1.4M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2026 | 20.08K | $1.44M | New |
About CVS and 13F data
CVS (CVS HEALTH CORP) is a Consumer Staples company. 39 other funds we track also report a position in CVS — the largest reported positions include Capital World Investors (US$7.75B), Capital World Investors (US$7.75B), Dodge & Cox (US$5.17B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CVS
- Capital World Investors 74.95M sh · $7.75B · Q2 2026
- Capital World Investors 74.95M sh · $7.75B · Q2 2026
- Dodge & Cox 50.01M sh · $5.17B · Q2 2026
- DODGE & COX 50.01M sh · $5.17B · Q2 2026
- Wellington Management Group 33.80M sh · $3.50B · Q2 2026
- WELLINGTON MANAGEMENT GROUP LLP 33.80M sh · $3.50B · Q2 2026
- DAVIS SELECTED ADVISERS 11.87M sh · $1.23B · Q2 2026
- Pzena Investment Management 11.77M sh · $1.22B · Q2 2026
- Clearbridge Investments, LLC 8.54M sh · $883.12M · Q2 2026
- GQG Partners LLC 7.96M sh · $822.99M · Q2 2026
More on Perbak Capital Partners LLP
FAQ
How long has Perbak Capital Partners LLP held CVS?
Perbak Capital Partners LLP has disclosed CVS holdings in 1 of the last 1 reported quarters, going back to Q1 2026.
What is Perbak Capital Partners LLP's current position in CVS?
As of Q1 2026, Perbak Capital Partners LLP holds 20.08K shares of CVS (CVS HEALTH CORP), valued at $1.44M, representing 0.35% of its reported portfolio and ranking #32.
Has Perbak Capital Partners LLP been buying or selling CVS?
In the latest 13F filing (Q1 2026), Perbak Capital Partners LLP newly opened its position in CVS.
Which other funds hold CVS?
Other major institutional holders of CVS include Capital World Investors, Capital World Investors, Dodge & Cox, among 39 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.